on 01 Jun 2021
Last Applicant/ Owned by
Paasheuvelweg 25
Amsterdam
NL
1105BP
Serial Number
88377819 filed on 09th Apr 2019
Registration Number
6367204 registered on 01st Jun 2021
Correspondent Address
Julianne Abelman
Filing Basis
1. intent to use
Disclaimer
NO DATA
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases Read More
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases
No 88377819
No Service Mark
No 879750
Yes
No
No
Yes
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 26th May 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 26th May 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 26th May 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 26th May 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 26th May 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 26th May 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 26th May 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 01st Jun 2021 | REGISTERED-PRINCIPAL REGISTER |
| 16th Mar 2021 | PUBLISHED FOR OPPOSITION |
| 16th Mar 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
